Fed Cuts Interest Rates, But Powell Spoils Santa Claus Rally; Dollar Surges To Over 2-Year High, Bitcoin Sinks Below $100,000: This Week In The Market
FDA Grants Accelerated Approval To Encorafenib With Cetuximab And MFOLFOX6 For Metastatic Colorectal Cancer With A BRAF V600E Mutation
UBS Maintains Neutral on Verizon Communications, Raises Price Target to $45
Verizon Communications Analyst Ratings
Top 3 Tech Stocks That Could Blast Off In Q4
The weight loss effect of the new drug was below expectations, and Novo-Nordisk A/S saw its stock plummet by 28% in Pre-Market Trading, while competitor Eli Lilly and Co surged over 12%.
The experimental results show that patients who received subcutaneous injections of CagriSema lost an average of 22.7% of their weight after 68 weeks. If volunteers who dropped out of the trial are included, the average weight loss effect decreases to 20.4%, both below the company's previous expectation of 25%.
Major technology companies are buying like crazy! Broadcom CEO: The AI spending frenzy will continue until 2030.
The CEO of Broadcom also stated that the company's clients are developing a three to five-year investment plan for AI infrastructure, progressing very rapidly. By 2027, Broadcom's clients will deploy up to 1 million chips in AI Chip clusters, and Broadcom's AI Chips could bring the company hundreds of billions of dollars in annual revenue growth.
CITIC SEC: How to view the impact of the FED's "hawkish" rate cut on US Technology stocks?
In the next 12 months, maintain an optimistic view on the US Technology Sector, with the Software SaaS Sector being the top pick, and the Hardware & Semiconductors Sector focusing on the two main lines of GenAI opportunity Diffusion and the cyclical industry recovery.
Futu Morning Report | Risk Assets Remain Weak! The Dow Jones ends a 10-day losing streak, while the S&P and Nasdaq have declined for three consecutive days; the USA House of Representatives did not pass the stopgap spending and debt ceiling bill.
The Dow Jones finished slightly higher, ending a 10-day losing streak, while Micron Technology fell over 16%. Intel is reportedly finalizing the shortlist for the next round of bidding for its ALTERA chip Business; Intel is reportedly finalizing the shortlist for the next round of bidding for its ALTERA chip Business.
Report: The sale process of Altera's chip Business is advancing, and Intel has identified the next round of potential buyers.
Intel has streamlined the list of potential buyers for its programmable chip division Altera, with several private equity firms including Apollo and Bain Capital advancing to the next round of bidding. Intel plans to ask bidders to submit formal Quotes by the end of January, with a valuation range between 9 billion and 12 billion dollars. Despite the change in CEO, Intel continues to firmly execute the previously announced plan. Following the announcement, Intel's stock price rose sharply.
Lumen Wireline Assets May Be Worth $7B-$10B in a Sale - Analyst
IShares MSCI USA Value Factor ETF Declares Quarterly Distribution of $0.748032
European Stocks That Trade Cheaper Than U.S. Peers
What the Options Market Tells Us About Intel
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Amazon Has 20,000 Rivian Electric Delivery Vans In Fleet: Here's What Could Be Next For Both Companies
UBS's Global Equity Focus List: Stocks Within Financial Technology
What's Going On With Applied Materials (AMAT) Stock?
Unpacking the Latest Options Trading Trends in Bank of America
AT&T To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Thursday